mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |